R esearchers in general, and specifically researchers in psychiatry, often bemoan their lack of funding support. In an era where money is scarce, such complaints may be seen as simply self-serving. It therefore becomes incumbent upon researchers in particular fields where funding may be particularly scarce to demonstrate that there is an inadequacy, and in turn, to propose solutions rather than continue to complain about the problem. In an article appearing in this issue, Drs. Raymond Lam and Nady el-Guebaly have clearly demonstrated the inadequacy of research funding for psychiatric disorders. They have also proposed solutions with a major emphasis on education and advocacy.
As Chairperson of the Canadian Alliance for Research on Schizophrenia (CARDS), I strongly support the suggestion of Drs. Lam and el-Guebaly that education of the public concerning mental illness and advocacy with respect to the need to fund research in this area will ultimately produce change and reap dividends. CARDS recognized the tremendous stigma against people with schizophrenia and therefore brought together scientists, clinicians, family members and consumers to propose a national strategy for schizophrenia research in this country. Although, practically speaking, our goal was to see peer-reviewed funding for schizophrenia research increase, the secondary goal was to begin to legitimize the disease and, in turn, the care of the disease through the legitimacy that comes from research excellence in a particular field. If schizophrenia and other mental illnesses are perceived as diseases worthy of academic investigations then this will ultimately have an impact on the perception of the disease as people make decisions about their careers both as researchers and clinicians. It will also alter the perception of the disease in the public arena and will therefore ultimately influence government. In turn, this altered perception leads to de-stigmatization which can only have a favourable effect on decisions to make funding for psychiatric research equitable to other disease areas.
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In a sense, CARDS became a flag around which to rally besides carrying out the activities already mentioned. Dr. Michael Smith, Canada's Nobel Laureate in Chemistry, perhaps recognized this fact when he recently donated half his Nobel Prize money toward the promotion of research training in schizophrenia. In a letter to the Medical Research Council of Canada, he wrote, "I am making this donation because I believe that schizophrenia, a serious mental illness, has not had the research attention that is warranted.... I also want the Canadian Alliance for Research on Schizophrenia, to be formally involved in this program." Dr. Smith's donation is of practical importance because it represents funding support for young researchers. Furthermore, British Columbia has pledged half a million dollars and the Schizophrenia Society of Canada has pledged three quarters of a million dollars to the same effort. The Medical Research Council of Canada will set up a series of scholarships and fellowships for research on schizophrenia, thus exponentially increasing the practical impact of Dr. Smith's gift. However, as with most gifts, it is actually not the gift itself but the "thought" that counts and in this case the thought comes from the mind of a Nobel Prize Laureate. His "thought" brings legitimacy to psychiatric research and to the disease of schizophrenia.
Those of us who are not Nobel Prize Laureates but who are still in a position to lend our influence and energies to improving the understanding of mental illness must also give thought as to how we can best improve public awareness and bring fairness to the research funding support for the illnesses that we treat.
Whether we are clinicians or researchers, we will bring legitimacy to ourselves and to our colleagues if we are successful. However, ultimately our greatest achievement will be to gradually de-stigmatize mental illness. People with mental illness must battle against the disease they possess. Let us not leave them to battle simultaneously against stigma and ignorance.
